The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment.

J Thromb Haemost

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Clinical Sciences and Community Health, Università degli Studi di Milano and IRCCS Maggiore Hospital Foundation, Milan, Italy.

Published: September 2017

Download full-text PDF

Source
http://dx.doi.org/10.1111/jth.13750DOI Listing

Publication Analysis

Top Keywords

recommended dose
4
dose idarucizumab
4
idarucizumab sufficient
4
sufficient sustained
4
sustained reversal
4
reversal dabigatran
4
dabigatran comment
4
recommended
1
idarucizumab
1
sufficient
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!